An oocyte donation protocol using the GnRH antagonist ganirelix acetate, does not compromise embryo quality and is associated with high pregnancy rates

Archives of Gynecology and Obstetrics

Volumn 272, Issue 1, 2005, Pages 1-6

  Vlahos, N F ^a   Bankowski, B J ^a   Zacur, H A ^a   Garcia, J E ^a   Wallach, E E ^a   Zhao, Y ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Ganirelix acetate; GnRH antagonist; IVF; Oocyte donor

Indexed keywords

GANIRELIX; GONADORELIN ANTAGONIST; GONADOTROPIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MALE; OOCYTE DONATION; PREGNANCY RATE;

ADULT; EMBRYO TRANSFER; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; OOCYTE DONATION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE;

EID: 21244446688     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-005-0726-2     Document Type: Article

References (35)

1. Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS (1984) Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 2(8414):1284-1285
2. Shaw RW, Ndukwe G, Imoedemhe DA, Bernard AG, Burford G (1985) Twin pregnancy after pituitary desensitisation with LHRH agonist and pure FSH. Lancet 2(8453):506-507
3. Ben-Rafael Z, Lipitz S, Bider D, Mashiach S (1991) Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle- stimulating hormone levels. Fertil Steril 55(2):272-275
4. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T et al (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9(5):788-791
5. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67(5):917-922
6. Olivennes F, Fanchin R, Bouchard P, Taieb J, Selva J, Frydman R (1955) Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum Reprod 10(6):1382-1386
7. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K et al (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 15(3):526-531
8. Borm G, Mannaerts B (2000) Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 15(7):1490-1498
9. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L et al (2000) Prospective, randomized, controlled study of in vitro fertilization- embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 73(2):314-320
10. Al-Inany H, Aboulghar M (2001) Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 4
11. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ et al (2001) Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 75(1):38-45
12. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, et al (2002) Stimulation and growth of antrat ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87(3):1156-1161
13. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli De Fatis C, et al (2001) Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab 86(1):337-343
14. Fraser HM, Lunn SF, Morris KD, Deghenghi R (1997) Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. Hum Reprod 12(3):430-435
15. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A et al (2002) Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 78(5):1025-1029
16. Tavaniotou A, Albano C, Smitz J, Devroey P (2002) Impact of ovarian stimulation on corpus luteum function and embryonic implantation. J Reprod Immunol 55(1-2):123-130
17. Noyes RW, Hertig AT, Rock J (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122(2):262-263
18. Garcia JE, Acosta AA, Hsiu JG, Jones HW Jr (1984) Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin/human chorionic gonadotropin for in vitro fertilization. Fertil Steril 41(1):31-35
19. Chetkowski RJ, Kiltz RJ, Salyer WR (1997) In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril 68(2):292-297
20. Anonymous (2002) Guidelines for oocyte donation. Fertil Steril 77(6 Suppl 5):S6-S8
21. Kol S (2000) Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation? Hum Reprod 15(9):1881-1882
22. Das K, Stout LE, Hensleigh HC, Tagatz GE, Phipps WR, Leung BS (1991) Direct positive effect of epidermal growth factor on the cytoplasmic maturation of mouse and human oocytes. Fertil Steril 55(5):1000-1004
23. Dekel N, Sherizly I (1985) Epidermal growth factor induces maturation of rat follicle-enclosed oocytes. Endocrinology 116(1):406-409
24. Hernandez ER (2000) Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 15(6):1211-1216
25. Cross JC, Werb Z, Fisher SJ (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266(5190):1508-1518
26. Hershkovitz E, Marbach M, Bosin E, Levy J, Roberts CT Jr, LeRoith D et al (1993) Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors. J Clin Endocrinol Metab 77(4):963-968
27. Kleinman D, Roberts CT Jr, LeRoith D, Schally AV, Levy J, Sharoni Y (1993) Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75. Regul Pept 48(1-2):91-98
28. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN (1995) Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab 80(2):430-434
29. Del Gadillo JC, Siebzehnrubl E, Dittrich R, Wildt L, Lang N (2002) Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol 102(2):179-183
30. Olivennes F (2002) GnRH antagonists: do they open new pathways to safer treatment in assisted reproductive techniques? Reprod Biomed Online 5(Suppl 1(3)):20-25
31. Olivennes F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R (2002) The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 8(3):279-290
32. Albano C, Smitz J, Tournaye H, Riethmuller-Winzen H, Van Steirteghem A, Devroey P (1999) Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. Hum Reprod 14(6):1426-1430
33. Lewin A, Benshushan A, Mezker E, Yanai N, Schenker JG, Goshen R (1994) The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertil Steril 62(1):121-125
34. Itskovitz-Eldor J, Kol S, Mannaerts B (2000) Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Hum Reprod 15(9):1965-1968
35. Kol S, Itskovitz-Eldor J (2000) Severe OHSS: yes, there is a strategy to prevent it! Hum Reprod 15(11):2266-2267